U.S. limits use of Regeneron, Eli Lilly COVID-19 antibody treatments amid Omicron spread

3 months ago 109
Last month, the U.S. had paused the organisation of Regeneron and Lilly's treatments and said the halt would proceed until caller information emerges connected their efficacy against Omicron.
Read Entire Article